Browsing by Author Block, Alan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
15-May-2011Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)Vanrenterghem, Yves; Bresnahan, Barbara; Campistol, Josep; Durrbach, Antoine; Grinyo, Josep; Neumayer, Hans-Hellmut; Lang, Philippe; Larsen, Christian P.; Mancilla-Urrea, Eduardo; Pestana, Jose Medina [UNIFESP]; Block, Alan; Duan, Tao; Glicklich, Alan; Gujrathi, Sheila; Vincenti, Flavio; Univ Hosp Leuven; Med Coll Wisconsin; Univ Barcelona; Univ Paris 11; Univ Hosp Bellvitge; Univ Med; Hosp Henri Mondor; Emory Univ; Inst Nacl Cardiol Dr Ignacio Chavez; Universidade Federal de São Paulo (UNIFESP); Bristol Myers Squibb Co; Univ Calif San Francisco
27-Dec-2010Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT StudiesLarsen, Christian P.; Grinyo, Josep; Medina-Pestana, Jose [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Breshahan, Barbara; Campistol, Josep M.; Florman, Sander; del Carmen Rial, Maria; Kamar, Nassim; Block, Alan; Di Russo, Gregory; Lin, Chen-Sheng; Garg, Pushkal; Charpentier, Bernard; Emory Univ; Univ Hosp Bellvitge; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; Univ Calif San Francisco; Med Coll Wisconsin; Univ Barcelona; Mt Sinai Med Ctr; Inst Nefrol; CHU Rangueil; Bristol Myers Squibb Co; Univ Paris S 11
1-Apr-2010Outcomes as a Function of Donor Criteria from a Phase III Study of Belatacept vs Cyclosporine in Kidney Transplantation (BENEFIT-EXT).Florman, Sander; Durrbach, Antoine; Larsen, Christian; Pestana, Jose Osmar Medina [UNIFESP]; Vanrenterghem, Yves; Vincenti, Flavio; Block, Alan; Garg, Pushkal; Copley, J. Brian; Xing, Jun; Grinyo, Josep; Mt Sinai Med Ctr; Emory Univ; Universidade Federal de São Paulo (UNIFESP); Univ Hosp Leuven; UCSF; Bristol Myers Squibb Co; Univ Hosp Bellvitge